Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral InnovationRevolutionary Oral Interferon Technology Combines Unmatched Advantages and Global Potential in the $16 Billion Coronavirus Market
Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025Report highlights greater visibility in AI Nose developments, including robotics, smart manufacturing, elderly care monitoring, and women's health testing
CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONAThe following CORRECTS and REPLACES the release that was issued earlier today: Updated partner for VOC detection platform development
Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONAFrom giving AI the sense of smell and breakthrough in rare disease treatments, Ainos is shaping 2025 with bold technologies and strategic collaborations
Ainos Reports Third Quarter 2024 Financial ResultsSecured multi-regional patent assets, strengthening Ainos' AI Nose technology.
Ainos to Participate in H.C. Wainwright 26th Annual Global Investment ConferenceCompany invites shareholders and all interested parties to learn our journey for ultimately becoming AI's nose capable of digitizing smell.
Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA TechnologiesAinos pioneers AI-powered digital nose technology with VOC detection breakthroughs for early disease diagnosis, industrial safety, and human-like sensory capabilities in robots
Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing SafetyAI Nose now has a 79% accuracy in identifying 761 samples across 22 VOCs in Japanese semiconductor manufacturing factories
